Worldwide Healthcare News

  Rise in incidence of sports-related injuries, supportive government initiatives, and increase in awareness about physical fitness are anticipated toboost the growth of the global sports medicine devices market.   The report offers an extensive analysis of the changing trends, key market segments, drivers and opportunities, competitive landscape, top investment pockets among others. According to the report, the global  sports medicine devices market  accrued $7.17 billion in 2017 and is expected to reach $12.73 billion by 2025, growing at a CAGR of 7.3% from 2018 to 2025. Rise in incidence of sports-related injuries, increase in awareness about physical fitness, and supportive government initiatives drive the growth of the industry. However, dearth of skilled professionals and lack of guidance on appropriate administration of sports medicines hinder the market growth. On the other hand, surge in demand for minimally invasive surgeries would create new opportunities for the market play

The report provides detailed analyses of the top winning strategies, market share & estimations, driving factors & opportunities, key market segments, and competitive landscape. As per the report, the global   dental consumables market   was pegged at $41.06 billion in 2017 and is expected to garner $55.58 billion by 2023, growing at a CAGR of 5.2% through 2023. High prevalence of dental diseases among geriatric population, surge in dental tourism across emerging economies, and increase in demand for minimally invasive dental procedures drive the growth of the global dental consumables market. Moreover, increase in awareness about oral hygiene supplements the market growth. However, high cost of dental products along with very limited reimbursement hampers the growth of the market. On the contrary, rise in demand for dental cosmetic procedures and increase in awareness about proper dentition are expected to provide lucrative opportunities for the market players in the near futu

  Surgical navigation systems market   was valued at $628 million in 2015, and is projected to reach $963 million by 2022, growing at a CAGR of 6.3% from 2016 to 2022, according to a new report published by Allied Market Research. Optical navigation systems segment is expected to grow at the highest growth rate during the forecast period, owing to benefits such as minimum radiation exposure and preciseness & accuracy during complex surgeries. The major factors that drive the growth of this market include rise in adoption of minimal invasive surgeries, improvement in healthcare infrastructure in emerging economies, numerous technological advancements, increase in incidence of ENT and neurosurgery-related disorders, and growth in knee replacement surgeries globally. However, high cost of these systems and stringent FDA rules are the major barriers that restrain the market growth. Get access to detailed report at:   https://www.alliedmarketresearch.com/surgical-navigation-systems-mark

The   radiology information system market   was valued at $603 million in 2015, and is projected to reach $941 million by 2022, growing at a CAGR of 5.9% from 2016 to 2022. The integrated radiology information systems segment held over three-fifths share of the total market in 2015. Radiology information system (RIS) is a computer networked system used to organize and manage the workflow of medical imagery and radiology department, supporting business analysis in a department. RIS is widely used along with picture archiving and communication system (PACS) and vendor neutral archive to manage billing, record keeping, and image archives. The integrated radiology information systems held the largest share in 2015 and is expected to grow at the highest CAGR of 6.0% during the analysis period. This is owing to the surging adoption and demand of integrated healthcare information technology platforms in various healthcare organization for easy operations to curb over expense and provide quali

  Global  Meningococcal Vaccine Industry  garnered $1.93 billion in 2018, and is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% from 2019 to 2026. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. Prime determinants of growth Rise in outbreaks of meningococcal disease, increase in immunization programs across the world, and surge in research and development for vaccine technology drive the global meningococcal vaccine market. However, long duration required for vaccine production and high cost of vaccine development hinder the market growth. On the other hand, increase in healthcare expenditure and untapped potential in emerging economies create new opportunities in the coming years. Covid-19 scenario: The global lockdown has paused the immunization programs. However, in certain regions the program schedules wo

The global   infusion pumps & accessories market   was valued at $6,478 million in 2016, and is estimated to reach $9,512 million at a CAGR of 5.6% from 2017 to 2023. Infusion pumps are medical devices employed to deliver medications and fluids into patient’s body in controlled dosages. They are designed according to the usage; for example, for stationary use, the device is placed at patient bedside, and for ambulatory use, they can be wearable or portable. Infused fluids are various medications that are administered on the basis of patient conditions such as nutrients for eternal feeding, insulin, hormones, antibiotics, and others. Moreover, these pumps are widely used in healthcare settings such as patient, outpatient, private clinics, and at-home settings. The major factors that drive the growth of the infusion pumps & accessories market include increase in incidence of chronic diseases such as diabetes, cardiovascular disorders, and cancer; growth in geriatric population wh

According to a new report published by Allied Market Research, titled, “the global  drug screening market  was valued at $5,214 million in 2016, and is projected to reach $9,447 million by 2026, growing at a CAGR of 8.7% from 2017 to 2026. North America held the largest market share with more than fifty percent share in 2016.” North America held five-ninths of the market share in global drug screening market, and is expected to continue this trend due its large amount of drug abuse and adoption of drug screening devices in the region. Drug screening is carried out to detect the presence of any illegal drug in the different biological samples such as blood or urine. Biological samples derived from the subject are tested under drug screening devices to diagnose the nature and amount of drug in the system. Drug screening manufacturers provide a wide range of high-tech equipment which is used by organizations and law enforcement agencies to check the presence of any illegal drug in the bod

The  lateral flow immunoassay based rapid test industry  was estimated at $4.72 billion in 2018 and is expected to reach $8.49 billion by 2026, growing at a CAGR of 7.6% from 2019 to 2026. The report provides an extensive analysis of the market dynamics including drivers & restraints, major winning strategies, market size & projections, competitive landscape, and major segments. Advantages of LFIA based rapid tests over laboratory testing, increase in initiatives of government and nonprofit organizations toward health awareness, and surge in healthcare expenditure all over the world drive the growth of the global lateral flow immunoassay based rapid test market. On the other hand, inadequate reimbursement policies for LFIA based rapid test diagnostics restraint the growth to some extent. However, growth prospects in the developing markets, and rise in prevalence of various chronic and infectious diseases worldwide are estimated to offer a number of opportunities for the key pla

  Rising demand of non-invasive & minimally invasive surgery and growing geriatric population play a major role in the growth of the powered surgical instrument market. Furthermore, rise in medical tourism in developing countries is expected to boost the market growth in the coming years. High prevalence of chronic disease rise in global geriatric population and increase in healthcare expenditure are expected to propel the growth of the global powered surgical instrument market.   The report offers detailed insights on the top investment pockets, market size & estimations, growth factors & opportunities, strategic developments, and competitive landscape. According to the report, the global powered surgical instrument market was pegged at $1.94 billion in 2017 and is expected to garner $2.73 billion by 2025, registering a CAGR of 4.2% through 2025. Handpieces segment to dominate the market throughout the study period   The handpieces segment held the largest share in 2017, c

  According to the report, the global   body contouring devices market   garnered $933 million in 2017 and is expected to reach $3,446 million, registering a CAGR of 17.7% from 2018 to 2025. Increase in obesity worldwide, rise in aesthetic consciousness, and advancements in the field of body contouring facilitate the growth in the market. However, high cost related to body contouring procedures restrains market growth. On the other hand, the increase in medical tourism and untapped potential in emerging economies create new opportunities. Body contouring devices have gained a substantial market share in recent years due to rise in obesity globally. In addition, surge in esthetic consciousness across the globe is another major factor that in turn has fueled the use of body contouring devices. Furthermore, untapped potential in the emerging markets in Asia-Pacific is anticipated to boost the market growth in the future. End users analyzed in the research include hospitals & clinics,

  According to the report, the global multiple sclerosis therapies (IVA) industry garnered $22.99 million in 2018, and is estimated to reach $28.00 million by 2026, registering a CAGR of 2.5% from 2019 to 2026. Drivers, restraints, and opportunities- Increase in number of pipeline drugs, surge in patient population, and rise in number of patient assistance programs (PAPs) drive the global multiple sclerosis therapies market. However, unspecified etiology of the disease restrains the market growth. On the other hand, the introduction of disease-modifying drugs and usage of off-label drugs will create new opportunities in the coming years.  Significant rise in number of pipeline drugs is a key factor that contributes toward the growth of the global multiple sclerosis therapies market along with increase in patient base suffering from multiple sclerosis. Furthermore, surge in number of patient assistance programs and similar initiatives undertaken by the government of various countries ar